Reduced Pain and Improved Function Following Short-Term Use of Noninvasive BioWave High Frequency Peripheral Nerve Stimulation for Pain Management

ConclusionThis survey is amongst the largest population sizes every studied for noninvasive neuromodulation. Within just 2  weeks patients can see a reduction in overall pain and medication needs. Although survey studies have inherent limitations such as duration and compliance biases with such an overwhelming benefit in every category we believe that noninvasive neuromodulation therapy is a promising, safe, and cost-e ffective therapy. Future studies should focus on long-term follow-ups and post-therapy pain scores with a placebo group.
Source: Pain and Therapy - Category: Anesthesiology Source Type: research